Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Treatment options for multidrug-resistant (MDR) bacterial infections are limited and often less effective. Non-pharmacologic approaches to preventing or treating MDR infections are currently restricted to improved antimicrobial stewardship and infection control practices. Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization. A total of eight case reports have been published showing FMT resulted in intestinal decolonization of extended spectrum β-lactamase (ESBL)-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant Enterococci, or methicillin-resistant Staphylococcus aureus. The procedure has been shown to work even in immunocompromised patients and those experiencing medical crises without any adverse events. Five trials are currently underway to further investigate the use of FMT for MDR bacterial decolonization. FMT is a completely novel way to eradicate drug-resistant bacteria from the intestinal reservoir and should be further investigated to address the global problem of difficult-to-treat, MDR bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 15×
“The case report did not mention pretreatment with bowel lavage or antibiotics before FMT.”
BackgroundMethodInfluentialHsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564 · cited 1×
“In the absence of knowledge about which bacterial species are necessary for protection, albeit this is an active area of research,[15] the most promising approach may be fecal microbiota transplantation (or FMT).”
BackgroundThe role of the gut microbiota in energy metabolism and metabolic disease
Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · cited 1×
“[46,47] Intestinal microbiota replacement via FMT may also impact factors beyond intestinal homeostasis such as the function of the immune system or the metabolic and neuropsychological [48,49] health of recipients.”
BackgroundYoungster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
Jenq, R. R., Ubeda, C., Taur, Y., Menezes, C. C., Khanin, R., Dudakov, J. A., Liu, C., West, M. L., Singer, N. V., Equinda, M. J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112408 · Cited by 626 · cited 1×
“For example, there has been a long history of studying the gut microbiota and its contribution to acute graft versus host disease in stem cell transplant recipients.[46,47] Intestinal microbiota replacement via FMT may also impact factors beyond intestinal homeostasis such as the function of the immune system or the m…”
BackgroundUbeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N. C., Equinda, M., Lipuma, L., Ling, L., Gobourne, A., No, D., et al. (2013) · Infection and Immunity · doi:10.1128/iai.01197-12 · Cited by 466 · cited 2×
“[13] In addition, a microbiota including the anaerobic species Barnesiella was reported to provide resistance to VRE.[14] Based on this, an approach to restore a healthy intestinal microbiota to prevent or clear MDR colonization is particularly attractive.”
BackgroundNeemann, K., Eichele, D. D., Smith, P. W., Bociek, R., Akhtari, M., & Freifeld, A. (2012) · Transplant Infectious Disease · doi:10.1111/tid.12017 · Cited by 107 · cited 1×
“In the few case reports involving FMT for CDI after allogeneic hematopoietic stem cell transplantation, no increases in graft versus host disease have been reported in the recipients.[44,45] Most adverse events appear to be associated with FMT delivery by colonoscope.”
BackgroundCrum-Cianflone, N. F., Sullivan, E., & Ballon-Landa, G. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00820-15 · Cited by 103
Cited by
The role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 357
Nutrition and the gut microbiome in the elderly
Salazar, N., Valdés-Varela, L., González, S., Gueimonde, M., & de los Reyes-Gavilán, C. G. (2017) · Gut Microbes · doi:10.1080/19490976.2016.1256525 · Cited by 282
“Only few of them were made with the aim of testing the effect of probiotics on the gut microbiota composition (Table 2) but mainly to assess the efficacy of these strains in gastrointestinal disorders associated with age, such as constipation, and diarrhea due to antibiotics consumption or associated with CDI.105 Some…”
BackgroundAntimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach
Bassetti, M., Poulakou, G., Ruppe, E., Bouza, E., Van Hal, S. J., & Brink, A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4878-x · Cited by 277
Ji, S. K., Yan, H., Jiang, T., Guo, C. Y., Liu, J. J., Dong, S. Z., Yang, K. L., Wang, Y. J., Cao, Z. J., & Li, S. L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01208 · Cited by 106
“…efficient approach to gut microbiota reprogramming through introducing xenomicrobiota into the gut (Cammarota et al., 2014; Khoruts and Sadowsky, 2016; Li et al., 2016; Manges et al., 2016), and has been recommended to be performed therapeutically (Bagdasarian et al., 2015; Cammarota et al., 2017).”
BackgroundMethodYip, A. Y. G., King, O. G., Omelchenko, O., Kurkimat, S., Horrocks, V., Mostyn, P., Danckert, N., Ghani, R., Satta, G., Jauneikaite, E., et al. (2023) · doi:10.1101/2023.03.25.533086 · Cited by 91
Metadata
- Authors
- Manges, A. R., Steiner, T. S., & Wright, A. J.
- Venue
- Infectious Diseases
- Publisher
- Informa UK Limited
- Published
- 2016-05-19
- Volume
- 48
- Issue
- 8
- Pages
- 587-592
- ISSN
- 0036-5548 (ISSN-L)
- 2374-4235
- 2374-4243
- OpenAlex
- W2408071371
- Cited by
- 117
- References
- 9
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.